Wuhan Thalys Medical Technology Inc. provided preliminary earnings guidance for the first quarter of 2018. The company predicts that the net profit belonging to shareholders of the listed company in the first quarter of 2018 will increase by between RMB 7.5 million and RMB 12 million (based on the disclosed statistics according to relevant regulations), with an increase of between 50% and 80% compared with the same period of the year before. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 7.5 million and RMB 12 million, with an increase of between 50% and 80% compared with the same period of the year before.